Prevention of sudden cardiac death in patients with chronic kidney disease: Risk and benefits of the implantable cardioverter defibrillator

Journal of Interventional Cardiac Electrophysiology

Volumn 35, Issue 2, 2012, Pages 227-234

  Hoffmeister, Jana M ^a   Estes III, N A Mark ^a   Garlitski, Ann C ^a  

^a TUFTS MEDICAL CENTER   (United States)

Author keywords

Chronic kidney disease; Complications; End stage renal disease; Implantable cardioverter defibrillator (ICD); Mortality

Indexed keywords

CHRONIC KIDNEY DISEASE; COMORBIDITY; CREATININE CLEARANCE; GLOMERULUS FILTRATION RATE; HUMAN; IMPLANTABLE CARDIOVERTER DEFIBRILLATOR; KIDNEY FUNCTION; MORTALITY; PRIORITY JOURNAL; PROGNOSIS; RANDOMIZED CONTROLLED TRIAL (TOPIC); REVIEW; RISK BENEFIT ANALYSIS; SUDDEN DEATH;

DEATH, SUDDEN, CARDIAC; DEFIBRILLATORS, IMPLANTABLE; HUMANS; PRIMARY PREVENTION; RENAL DIALYSIS; RENAL INSUFFICIENCY, CHRONIC; RISK FACTORS;

EID: 84869880634     PISSN: 1383875X     EISSN: 15728595     Source Type: Journal    
DOI: 10.1007/s10840-012-9711-4     Document Type: Review

References (29)

1. Moss, A., Hall, W., Cannom, D., Daubert, J., Higgins, S., Klein, H., et al. (1996). Improved survival with an implanted defibrillator in patients with coronary disease at high risk for ventricular arrhythmia. Multicenter automatic defibrillator implantation trial investigators. The New England Journal of Medicine, 335(26), 1933-1940.
2. Moss, A., Zareba, W., Hall, W., Klein, H., Wilber, D., Cannom, D., et al. (2002). Prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction. The New England Journal of Medicine, 346, 877-883.
3. Kadish, A., Dyer, A., Daubert, J., Quigg, R., Estes, N., Anderson, K., et al. (2004). Prophylactic defibrillator implantation in patients with nonischemic dilated cardiomyopathy:Defibrillators in Non- Ischemic Cardiomyopathy Treatment Evaluation (DEFINITE) Investigators. The New England Journal of Medicine, 350(21), 2151-2158.
4. Buxton, A., Lee, K., Fisher, J., Josephson, M., Prytowsky, E., & Hafley, G. (1999). A randomized study of the prevention of sudden death in patients with coronary artery disease. Multicenter Unsustained Tachycardia Trial Investigators. New England Journal of Medicine, 341, 1882-1890.
5. Bardy, G., Lee, K., Mark, D., & Investigators, S.-H. (2005). Amiodarone or an implantable cardioverter-defibrillator for congestive heart failure. The New England Journal of Medicine, 352 (3), 225-237.
6. NKF KDOQI Clinical Practice Guidelines for Chronic Kidney Disease: Evaluation, Classification, and Stratification (2002). http://www.kidney.org/ professionals/kdoqi/guidelines-ckd/p4-class-g1.htm. Accessed July 11 2012.
7. Coresh, J., Astor, B., Greene, T., Coresh, J. A. B., Greene, T., Eknoyan, A.& Levey, A. S. (2003). Prevalence of chronic kidney disease and decreased kidney function in the adult U.S. population. American Journal of Kidney Diseases, 41, 1-12.
8. Alsheikh-Ali, A., Trikalinos, T., Ruthazer, R., Terrin, N., Wong, J., Sarnak, M., et al. (2011). Risk of arrhythmic and nonarrhythmic death in patients with heart failure and chronic kidney disease. American Heart Journal, 161(1), 204-209.
9. Cuculich, P., Sánchez, J., Kerzner, R., Greenberg, S., Sengupta, J., Chen, J., et al. (2007). Poor prognosis for patients with chronic kidney disease despite ICD therapy for the primary prevention of sudden death. Pacing and Clinical Electrophysiology, 30(2), 207- 213.
10. Coca, S., Krumhoz, H., Garg, A., & Parikh, C. (2006). Underrepresentation of renal disease in randomized controlled trials of cardiovascular disease. Journal of the American Medical Association, 26(11), 1377-1384.
11. Strickberger, S., Hummel, J., Bartlett, T., Frumin, H., Schuger, C., Beau, S., et al. (2003). Amiodarone versus implantable cardioverter- defibrillator: randomized trial in patients with nonischemic dilated cardiomyopathy and asymptomatic nonsustained ventricular tachycardia-AMIOVIRT. JACC, 41(10), 1707-1712.
12. Steinbeck, G., Andresen, D., Senges, J., Hoffmann, E., Seidl, K., Brachmann, J., et al. (2004). Immediate risk-stratification improves survival (IRIS): study protocol. Europace, 6(392- 99).
13. Nanthakumar, K., Epstein, A., Kay, G., Plumb, V., & Lee, D. (2004). Prophylactic implantable cardioverter-defibrillator therapy in patients with left ventricular systolic dysfunction: a pooled analysis of 10 primary prevention trials. JACC, 44(11), 2166- 2172.
14. Hohnloser, S. H., Kuck, K., Dorian, P., Roberts, R. S., Hampton, J. R., Hatala, R., Fain, E., Gent, M., Connolly, S., & on behalf of the DINAMIT Investigators. (2004). Prophylactic use of an implantable cardioverter- defibrillator after acute myocardial infarction. New England Journal of Medicine, 351(24), 2481-2488.
15. Cannizzaro, L., Piccini, J., Patel, U., & Hernandez, A. (2011). Device therapy in heart failure patients with chronic kidney disease. JACC, 58(9), 889-896.
16. Bigger, J. (1997). Prophylactic use of implanted cardiac defibrillators in patients at high risk for ventricular arrhythmias after coronary-artery bypass graft surgery. Coronary Artery Bypass Graft (CABG) Patch Trial Investigators. The New England Journal of Medicine, 337(22), 1569-1575.
17. Bansch, D., Antz, M., Boczor, S., Volkmer, M., Tebbenjohanns, J., Seidle, K., et al. (2002). Primary prevention of sudden cardiac death in idiopathic dilated cardiomyopathy: the cardiomyopathy trial. Circulation, 105, 1453- 1458.
18. Sheldon, R., Connolly, S., Krahn, A., Roberts, R., Gent, M., & Gardner, M. (2000). Identification of patients most likely to benefit from implantable cardioverter-defibrillator therapy: the Canadian Implantable Defibillator study. Circulation, 101 (1660-1664).
19. Kuck, K., Cappato, R., Siebels, J., & Ruppel, R. (2000). Randomized comparizon of antiarrhythmic drug therapy with implantable defibrillators in patients resuscitated from cardiac arrest: the Cardiac Arrest Study Hamburg (CASH). Circulation, 102 (748-54).
20. Anderson, J., Hallstrom, A., Epstein, A., Pinski, S., Rosenberg, Y., Nora, M., et al. (1999). Design and results of the Antiarrhythmics Vs Implantable Defibrillators (AVID) registry. Circulation, 99, 1692-1699.
21. Hager, C., Jain, S., Blackwell, J., Culp, B., Song, J., & Chiles, C. (2010). Effect of renal function on survival after implantable cardiodefibrillator placement. The American Journal of Cardiology, 106(9), 1297-1300.
22. Amin, M., Fox, A., Kalahasty, G., Shepard, R., Wood, M., & Ellenbogen, K. (2008). Benefit of primary prevention implantable cardioverter-defibrillators in the setting of chronic kidney disease: a decision model analysis. Journal of Cardiovascular Electrophysiology, 19, 1275-1280.
23. Goldenberg, I., Moss, A., McNitt, S., Zareba, W., Andrews, M., Hall, W., et al. (2006). Relations among renal function, risk of sudden cardiac death, and benefit of the implanted cardiac defibrillator in patients with ischemic left ventricular dysfunction. American Journal of Cardiology, 98, 485- 490.
24. Charytan, D., Patrick, A., Liu, J., Setoquchi, S., Herzog, C., Brookhart, M., et al. (2011). Trends in the use and outcomes of implantable cardioverter-defibrillators in patients undergoing dialysis in the United States. American Journal of Kidney Diseases, 58 (3), 409-417.
25. Herzog, C., Li, S., Weinhandle, E., Strief, J., Collins, A., & Gilberston, D. (2005). Survival of dialysis patients after cardiac arrest and the impact of implantable cardioverter defibrillators. Kidney International, 68, 818-825.
26. Sakhuja, R., Keebler, M., Lai, T., McLaughlin, G., Thakur, R., & Bhatt, D. (2009). Meta-analysis of mortality in dialysis patients with an implantable cardioverter defibrillator. The American Journal of Cardiology, 103(5), 735-741.
27. Wase, A., Basit, A., Nazir, R., Jarnal, A., Shah, S., Khan, T., et al. (2004). Impact of chronic kidney disease upon survival among implantable cardioverter-defibrillator recipients. Journal of Interventional Cardiac Electrophysiology, 11, 199-204.
28. Aggarwal, A., Wang, Y., Rumsfeld, J., Curtis, J., & Heidenreich, P. (2009). Clinical characteristics and inhospital outcome of patients with end stage renal disease on dialysis referred for implantable converter defibrillator implantation. Heart Rhythm, 6, 1565-1571.
29. Tompkins, C., Mclean, R., Cheng, A., Brinker, J., Marine, J., Nazarian, S., et al. (2011). End-stage renal disease predicts complications in pacemaker and ICD implants. Journal of Cardiac Electrophysiology, 22(10), 1099-1104.